Crohn’s Disease Market is Expected to Grow at a CAGR of 12% from 2016 to 2022

Market Highlights
The global Crohn’s disease market has been evaluated as growing market and expected that the market will reach high growth figures in the coming future. Crohn's disease is a type of inflammatory bowel disease (IBD), caused by a combination of environmental, immune and bacterial factors in genetically prone individuals. There are no medications, drugs or surgical procedures that can cure or prevent Crohn's disease. It is expected that the disease affects about 3.2 per 1,000 people in Europe and North America. It is less common in Asia and Africa. Rates have, however, been growing, particularly in the developing world, since last few years.
The Crohn’s & Colitis Foundation of America (CCFA) stated, that over 1 Million Americans were diagnosed with Crohn's & ulcerative colitis disorders and diseases, with maximum of them aged above 30. Increasing occurrence of Crohn's disease has triggered a vigorous demand for its therapeutics. A survey conducted by the US Center for Disease Control (CDC) has discovered that the incidence rate of Crohn's disease in the country is 3.1 to 14.6 new cases per 100,000 population annually. The disease is highly predominant in developed countries, especially in individuals who smoke and consume alcohol.
Major factors leading to the growth of the market includes higher preference for symptomatic therapeutic, better treatment of inflammatory bowel diseases, arrival of enhanced drugs and healthier investments in R&D programs. High cost of treatment and lack of early diagnosis techniques are the major factor restricting the market growth.

North America is expected to account for the largest share of the global Crohn’s disease Market in 2016, followed by Europe, the region will continue to lead the pack during the forecast period. The emerging markets of China and India will also play a key role in driving growth in the long term, primarily due to the anticipated strong uptake of Remicade over the forecast period.

Key Players of Global Crohn’s Disease Market:
• Allergan, Inc.,
• AbbVie Inc.,
• Takeda Pharmaceutical Company Limited,
• Bayer AG,
• UCB S.A.,
• Perrigo Company plc,
• Pfizer Inc.,
• Johnson & Johnson Services, Inc.,
• Ferring B.V.

Request a Sample Copy @ https://www.marketresearchfuture.com/sample_request/2344

Segments:
Global Crohn’s Disease Market is segmented
Segmentation on the basis of procedures and drug type. Based on procedures, the market is segmented into colonoscopy, flexible sigmoidoscopy, computerized tomography (CT), magnetic resonance imaging (MRI), capsule endoscopy, double-balloon endoscopy and small bowel imaging.
Segmentation on the basis of drug type the market is classified into antibiotics, anti-diarrheal, immune system suppressors, pain relievers, and anti-inflammatory drugs.

Taste the market data and market information presented through more than 50 market data tables and figures spread in 110 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Global Crohn’s Disease Market Research Report - Forecast to 2022”

Commenting on the report, an analyst from Market Research Future (MRFR)’s team said: the market for Crohn’s disease is growing due to increasing demand for biologics for treating bowel disorders such as ulcerative collates and Crohn's disease is propelling the overall growth of Crohn's disease market. Higher inclination for symptomatic therapeutic and drugs over surgeries, better treatment and management of inflammatory bowel diseases, the arrival of advanced drugs in the market owing to healthier investments in R&D programs are some of the key trends governing the market. Moreover, drug manufacturers are actively focusing on advanced products having higher efficiency. The growing patient population is an additional factor anticipated to influence the market growth between 2016 and 2022. Therefore, higher application and preference for biologics and anti-inflammatory drug therapies coupled with the surging popularity of biosimilars are expected to play an important role in driving the market growth for the future. On the other hand, the high cost of treatment will remain as a major impediment for the market. Further, the patient expiry of blockbuster drugs and lack of early diagnosis particularly in third world countries are some of the other hindrances or restrictions that are likely to inhibit the market growth during the forecasted period.

Access Report Details @ https://www.marketresearchfuture.com/reports/crohns-disease-market

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Table of Content
1 Introduction
1.1 Definition
1.2 Scope Of Study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.2.2.1 Assumptions
1.2.2.2 Limitations
1.3 Market Structure:
2 Research Methodology
2.1 Research Process:
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Porters Five Forces Model
4.2 Bargaining Power Of Suppliers
4.3 Bargaining Power Of Buyers
4.4 Threat Of New Entrants
4.5 Threat Of Substitutes
4.6 Intensity Of Rivalry
5 Global Crohn’s Disease Market, By Procedures
Continue………..

List Of Tables
Table 1 Global Crohn’s Disease Market, By Procedure, 2013-2022 (Usd Million)
Table 2 Global Crohn’s Disease Market, By Drug Type, 2013-2022 (Usd Million)
Table 3 Global Crohn’s Disease Market By Region 2013-2022 (Usd Million)
Continue…………..

List Of Figures
Figure 1 Research Process
Figure 2 Porters Five Forces Model
Figure 3 Global Crohn’s Disease Market, By Procedure
Figure 4 Global Crohn’s Disease Market, By Drug Type
Figure 5 Global Crohn’s Disease Market, By Region
Figure 6 Global Crohn’s Disease Market: Company Share Analysis, 2015 (%)
Continue………………

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:
Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: akash.anand@marketresearchfuture.com

This release was published on openPR.